GL1X · GenesisL1 explorer

MolNFT v1 · #149615 · protein

Crystal structure of human SP100 in complex with bromodomain-focused fragment XS039818E 1-(3-phenyl-1,2,4-oxadiazol-5-YL)METHANAMINE

6G5N · Nuclear autoantigen sp-100: “Crystal structure of human SP100 in complex with bromodomain-focused fragment XS039818E…”. X-ray diffraction, 3 ligands (ENK, ZN, CL), 3 pockets (best druggability 0.60). MolNFT v1 #149615 on GenesisL1…

PDB
6G5N
Type
protein
Length
346 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nuclear autoantigen sp-100
UniProt
P23497
Ligands
ENK, ZN, CL
Pockets
3 · best druggability 0.60

Structure

x-ray diffraction · 2 distinct chains · 49% helix, 6% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANuclear autoantigen sp-100protein17750% helix, 6% strandP23497
BNuclear autoantigen sp-100protein16949% helix, 6% strandP23497

Ligands and binding sites

  • ENK · (3-phenyl-1,2,4-oxadiazol-5-yl)methanamine · ligand · chains A
  • ZN · Zinc ion · metal · 4 copies · chains A, B
  • CL · Chloride ion · ion · chains B
  • EDO · 1,2-ethanediol · additive · 4 copies · chains A, B
  • MES · 2-(N-morpholino)-ethanesulfonic acid · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12120.600.8125MES, EDO
21710.490.7729EDO
3670.300.7416empty

Interfaces

1 interface between chains.

  • A–B · 541 Ų buried · 7 hydrogen bonds · protein-protein

Compared structures

  • 6G5N · Crystal structure of human SP100 in complex with bromodomain-focused fragment XS039818e… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.